Natera shared on X:
“Join David Russler-Germain and Rod Ramchandren for a live discussion of new real-world data from Galanina et al., Blood Neoplasia 2026, the largest real-world study of ctDNA–based MRD testing in lymphoma, spanning 144 patients across 14 subtypes.
Explore what these findings may mean for monitoring patients in everyday practice.”
You can also read:
Arpita Chauhan: ctDNA-MRD Testing Moves Into Clinical Decision-Making in Bladder Cancer
